Arca
Skip to content
Tools
Tools

Retinoic acid receptor

Family in Homo sapiens that 5 drugs act on.

  • Drugs that act on it: 5
  • Approved: 4
  • In phases 1 to 3: 1
  • Sponsors: 4
  • Genes: 3

Who is on it, and how far along

Every drug ChEMBL records acting on RARA, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 4
  • Other 1

Approved4

  • Tretinoin
  • Isotretinoin
  • Adapalene
  • Tazarotene

Phase 30

    Phase 20

      Phase 11

      • IRX4310

      Sponsors

      Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.

      The landscape

      Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. 4 of 5 act as: Retinoic acid receptor agonist; the rest name their own mechanism.
      TretinoinBoxed warningApprovedBausch HealthSmall moleculeAgonist63
      IsotretinoinBoxed warningApprovedRocheSmall moleculeAgonist28
      AdapaleneApprovedGalderma LaboratoriesSmall moleculeAgonist15
      TazaroteneApprovedChartwell RXSmall moleculeAgonist0
      IRX4310Phase 1—OtherAntagonistRetinoic acid receptor antagonist0

      Open trials

      The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 24 in all, from ClinicalTrials.gov.
      Combined Tretinoin and Tranexamic Acid Cream for Hyperpigmentation After ElectrosurgeryTretinoinPhase 2RecruitingWahyu LestariNov 19, 2026
      Naxitamab Enabled Transplant-Free Study in High-Risk NeuroblastomaIsotretinoinPhase 2RecruitingGiselle ShollerNov 12, 2026
      Clinical Evaluation of an Oil-Balancing Facial Sunscreen With Topical TretinoinTretinoinPhase 4Enrolling by invitationColgate PalmoliveNov 12, 2026
      Salicylic Acid Solution Versus Tretinoin 0.05% Cream for Treating Plane WartsTretinoinNot applicableNot yet recruitingCombined Military Hospital, PakistanNov 10, 2026
      Palbociclib, All-Trans Retinoic Acid, and Venetoclax in Relapsed or Refractory Acute Myeloid LeukemiaTretinoinPhase 1 / Phase 2Not yet recruitingSecond Affiliated Hospital of Nanchang UniversityNov 9, 2026
      Safety, Tolerability, and Clinical Effectiveness of Adapalene/Clindamycin Phosphate Gel (Klenzit®-C) in Vietnamese Patients With Mild to Moderate Acne VulgarisAdapalenePhase 4RecruitingIR INNOVATE RESEARCH PRIVATE LIMITEDNov 5, 2026
      Comparing Nadifloxacin Plus Tretinoin Versus Clindamycin Plus Tretinoin Creams for Mild-to-Moderate AcneTretinoinPhase 4RecruitingNishtar Medical UniversityNov 4, 2026
      Adapalene Gel for Acute Radiation-Induced Skin InjuryAdapaleneEarly phase 1RecruitingYunnan Cancer HospitalOct 21, 2026
      Comparison of Topical Clascoterone 1% Cream Versus Adapalene 0.1% Cream in the Treatment of Mild-to-Moderate Acne VulgarisAdapaleneNot applicableRecruitingPak Emirates Military HospitalOct 20, 2026
      Clascoterone Versus Clindamycin Added to Adapalene/Benzoyl Peroxide for Moderate Facial AcneAdapalenePhase 4Not yet recruitingAllied Hospital FaisalabadOct 19, 2026
      Testing Safe Doses of Anti-Cancer Medicines, 5-Flurouracil (5-FU) and Tretinoin (ATRA), Added to the Usual Cancer Treatment of EpendymomaTretinoinPhase 1 / Phase 2Not yet recruitingChildren's Oncology GroupSep 30, 2026
      Phase 1 Study of ATRA Plus a PD-1 Inhibitor in EGFR-Mutant NSCLC After Third-Generation EGFR-TKI ResistanceTretinoinPhase 1Not yet recruitingCancer Institute and Hospital, Chinese Academy of Medical SciencesSep 25, 2026
      Facial Skin Microbiome in Patients With Moderate-to-Severe Acne Vulgaris Treated With IsotretinoinIsotretinoin—RecruitingCan Tho University of Medicine and PharmacySep 22, 2026
      The Impact of Baseline Hormonal Profiles (DHEAS, FSH, LH) on Treatment Response to Systemic Isotretinoin in Adult Female Patients With Acne VulgarisIsotretinoin—RecruitingBiruni UniversitySep 14, 2026
      Radiofrequency Treatment Versus Topical Therapy for Facial Acne VulgarisAdapaleneNot applicableRecruitingJeisys Medical IncSep 4, 2026
      Topical Metformin Versus Triple Regimen for Epidermal MelasmaTretinoinPhase 2Not yet recruitingCombined Military Hospital, PakistanAug 21, 2026
      Comparison of Itraconazole With Itraconazole and Isotretinoin in the Treatment Duration, Safety a n d Cure Rate in Adult Patients of Tinea Corporis/ Cruris-A Randomised Controlled TrailIsotretinoinPhase 4Not yet recruitingPak Emirates Military HospitalJun 30, 2026
      Comparison of Topical Clascoterone and Adapalene for Mild Acne VulgarisAdapaleneEarly phase 1Not yet recruitingKhyber Teaching HospitalJun 29, 2026
      Low-Dose Versus Conventional-Dose Oral Isotretinoin for Acne VulgarisIsotretinoinPhase 4Not yet recruitingPakistan Institute of Medical SciencesJun 10, 2026
      Isotretinoin vs. Doxycycline for Acneiform Rash in Patients Receiving Drugs That Target the MAPK PathwayIsotretinoinPhase 2Not yet recruitingUniversity of California, San FranciscoJun 5, 2026
      Study to Assess Safety, Pharmacokinetics, and Treatment Effect of CabtreoAdapalenePhase 4RecruitingBausch Health Americas, Inc.Apr 13, 2026
      Isotretinoin vs hCG for Male Infertility Due to Low or Absent SpermIsotretinoinPhase 2Enrolling by invitationUniversity of NebraskaMar 18, 2026
      Topical 5% Spironolactone Gel Versus 0.1% Adapalene Gel for Acne Vulgaris: A Randomized Split-Face StudyAdapalenePhase 2Not yet recruitingAssiut UniversityMar 16, 2026
      Efficacy of Cosmetic Product RV3278B-OS0386 in the Maintenance Phase After Oral Isotretinoin Treatment of Adults Subjects With Facial Acne.IsotretinoinNot applicableActive, not recruitingPierre Fabre Dermo CosmetiqueJan 14, 2026

      Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2363069, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

      Esc

      Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

      Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.